+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Biologic"

From
From
From
From
From
From
From
Startup Series - Tech, genes, and beyond - transforming biotech - Product Thumbnail Image

Startup Series - Tech, genes, and beyond - transforming biotech

  • Report
  • December 2023
  • 70 Pages
  • Global
From
From
From
From
United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030 - Product Thumbnail Image

United Arab Emirates Retinal Biologics Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030

  • Report
  • January 2024
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
South America Cell Counting Market Outlook, 2030 - Product Thumbnail Image

South America Cell Counting Market Outlook, 2030

  • Report
  • June 2025
  • 80 Pages
From
France Cell Counting Market Overview, 2030 - Product Thumbnail Image

France Cell Counting Market Overview, 2030

  • Report
  • June 2025
  • 75 Pages
  • France
From
From
From
From
From
Biologics Markets in China - Product Thumbnail Image

Biologics Markets in China

  • Report
  • July 2024
  • 243 Pages
  • China
From
Loading Indicator

The biologic market is a subset of the biotechnology industry that focuses on the development and production of biologic drugs. Biologic drugs are made from living organisms, such as proteins, nucleic acids, and cells, and are used to treat a variety of diseases. These drugs are typically more complex and expensive to produce than traditional small-molecule drugs. The biologic market is highly competitive, with many companies vying for market share. The biologic market is divided into two main segments: therapeutic biologics and biosimilars. Therapeutic biologics are drugs that are developed to treat a specific disease or condition, while biosimilars are drugs that are similar to existing biologic drugs but are not identical. Some of the major players in the biologic market include Amgen, Biogen, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development, production, and marketing of biologic drugs. Show Less Read more